HuGE Literature Finder
Records
1
-
2
Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy. Breast cancer research and treatment 2012 Jan 131 (2): 653-61. Hein R, Abbas S, Seibold P, Salazar R, Flesch-Janys D, Chang-Claude |
Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk. American journal of epidemiology 2009 Nov 170 (10): 1241-9. Reding Kerryn W, Li Christopher I, Weiss Noel S, Chen Chu, Carlson Christopher S, Duggan David, Thummel Kenneth E, Daling Janet R, Malone Kathleen |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: